American International Group’s Icosavax, Inc. Common Stock ICVX Stock Holding History

American International Group’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,690	Closed	-$216K	–	3033
2023 Q4	$216K	Sell	13,690 -56	-0.4%	-$539	﹤0.01%	2136
2023 Q3	$107K	Buy	13,746 +489	+4%	+$4.05K	﹤0.01%	2480
2023 Q2	$132K	Buy	13,257 +2,529	+24%	+$20.2K	﹤0.01%	2412
2023 Q1	$62.2K	Buy	10,728 +214	+2%	+$1.85K	﹤0.01%	2653
2022 Q4	$83.5K	Sell	10,514 -39	-0.4%	-$167	﹤0.01%	2589
2022 Q3	$33K	Buy	10,553 +150	+1%	+$938	﹤0.01%	2919
2022 Q2	$60K	Sell	10,403 -1,602	-13%	-$12.5K	﹤0.01%	2819
2022 Q1	$85K	Buy	12,005 +4,896	+69%	+$77K	﹤0.01%	2653
2021 Q4	$163K	Sell	7,109 -213	-3%	-$5.5K	﹤0.01%	2485
2021 Q3	$217K	Buy	+7,322	New	+$248K	﹤0.01%	2389

American International Group's ICVX Position: Q1 2024 in Review

American International Group sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 13,690 shares — an estimated $216K sold.

American International Group first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $217K in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

American International Group reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
American International Group sold 13,690 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $216K.
American International Group first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
American International Group's Icosavax, Inc. Common Stock position peaked at $217K in Q3 2021.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on American International Group's 13F filing for Q1 2024, filed 13 May 2024.